{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:09Z","timestamp":1791429489794,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA\/NV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["VEO-000693"],"award-info":[{"award-number":["VEO-000693"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ypmed.2026.108521","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:22:50Z","timestamp":1769469770000},"page":"108521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Co-administration of recombinant zoster vaccine with other recommended vaccines among older adults in the United States of America"],"prefix":"10.1016","volume":"204","author":[{"given":"Justin","family":"Gatwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Stempniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2026.108521_bb0005","author":"Agency for Healthcare Research and Quality"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/14760584.2025.2514517","article-title":"Trends in co-administration of adult vaccinations in the US retail pharmacy setting","volume":"24","author":"Agrawal","year":"2025","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.ypmed.2026.108521_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine co-administration in adults: an effective way to improve vaccination coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ypmed.2026.108521_bb0025","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ypmed.2026.108521_bb0030","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ypmed.2026.108521_bb0035","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.ypmed.2026.108521_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.ypmed.2026.108521_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.ypmed.2026.108521_bb0050","author":"Environmental Systems Research Institute"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2317595","article-title":"Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: qualitative interviews with healthcare providers and patients","volume":"20","author":"George","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"issue":"4","key":"10.1016\/j.ypmed.2026.108521_bb0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2105\/AJPH.2011.300512","article-title":"Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers","volume":"102","author":"Gilchrist","year":"2012","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.ypmed.2026.108521_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm. Rep."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amepre.2024.02.013","article-title":"COVID-19 and influenza vaccine coadministration among older U.S. adults","volume":"67","author":"Harris","year":"2024","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2026.108521_bb0075","author":"Health Resources & Servies Administration"},{"key":"10.1016\/j.ypmed.2026.108521_bb0080","author":"Hung"},{"key":"10.1016\/j.ypmed.2026.108521_bb0085","author":"IQVIA"},{"issue":"15","key":"10.1016\/j.ypmed.2026.108521_bb0090","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.vaccine.2022.03.006","article-title":"Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017-2021","volume":"40","author":"LaMori","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2525603","article-title":"The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024","volume":"21","author":"Li","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"issue":"29","key":"10.1016\/j.ypmed.2026.108521_bb0100","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1016\/j.vaccine.2018.05.110","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults \u226550\u00a0years of age: a randomized trial","volume":"36","author":"Marechal","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108521_bb0105","first-page":"490","article-title":"The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged \u226550 years: a randomized trial","volume":"84","author":"Min","year":"2022","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.ypmed.2026.108521_bb0110","author":"Norris"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2361946","article-title":"Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020-May 19, 2023","volume":"20","author":"Parker","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8","key":"10.1016\/j.ypmed.2026.108521_bb0120","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2608.191493","article-title":"Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States","volume":"26","author":"Patel","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ypmed.2026.108521_bb0125","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.japh.2021.11.010","article-title":"Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: a retrospective pharmacy and medical claims analysis","volume":"62","author":"Patterson","year":"2022","journal-title":"J. Am. Pharm. Assoc. (2003)"},{"issue":"6","key":"10.1016\/j.ypmed.2026.108521_bb0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108521_bb0135","article-title":"Safety and immunogenicity of co-administration of herpes zoster vaccines with other vaccines in adults: a systematic review and meta-analysis","volume":"13","author":"Rezahosseini","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.ypmed.2026.108521_bb0140","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jix481","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine coadministered with seasonal influenza vaccine in adults aged 50 years or older","volume":"216","author":"Schwarz","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ypmed.2026.108521_bb0145","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/21645515.2019.1660119","article-title":"The pharmacist and pharmacy have evolved to become more than the corner drugstore: a win for vaccinations and public health","volume":"16","author":"Shen","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"39","key":"10.1016\/j.ypmed.2026.108521_bb0150","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1016\/j.vaccine.2019.08.001","article-title":"The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged \u226550 years: a randomized trial","volume":"37","author":"Strezova","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ypmed.2026.108521_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70090","article-title":"Adult vaccine coadministration is safe, effective, and acceptable: results of a survey of the literature","volume":"19","author":"Tan","year":"2025","journal-title":"Influenza Other Respir. Viruses"},{"issue":"6","key":"10.1016\/j.ypmed.2026.108521_bb0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/idr14060098","article-title":"The importance of COVID-19\/influenza vaccines co-administration: an essential public health tool","volume":"14","author":"Venuto","year":"2022","journal-title":"Infect. Dis. Rep."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13690-024-01260-1","article-title":"Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review","volume":"82","author":"Wennekes","year":"2024","journal-title":"Arch. Public Health"},{"key":"10.1016\/j.ypmed.2026.108521_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100397","article-title":"Efficacy and safety of the recombinant zoster vaccine: a systematic review and meta-analysis","volume":"15","author":"Zeevaert","year":"2023","journal-title":"Vaccine X"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108521_bb0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14760584.2024.2441255","article-title":"Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018-2024: a database study","volume":"24","author":"Zheng","year":"2025","journal-title":"Expert Rev. Vaccines"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:28:11Z","timestamp":1782030491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743526000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S0091743526000277"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108521","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of recombinant zoster vaccine with other recommended vaccines among older adults in the United States of America","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 GlaxoSmithKline Biologicals SA. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108521"}}